ACTC: if successful in future to capture even 10% of that market in humans, you today are buying like shares of BRKA.
OAB meeting is about 3 weeks away, Time to get excited here at Actc. ACTC PPS is about to take off and never look back again. The RPE program Billions will fund all other programs just in case big pharma is late to the party.
This all sounds fine for some future endeavor, but wouldn’t it make more sense to put the money it will cost into the Macular Degeneration phases and get it to market. Then you would have funds available for future projects.
Here's a POV: Millions of visually healthy humans will spend enormous amounts on curing their pets.
Then perhaps ACTC will have profits to continue MD research and testing. I've been wondering when these patents would be put to work. They may be GOLD.
Re: .....but wouldn’t it make more sense to put the money it will cost into the Macular Degeneration phases and get it to market........
Recall the adult stem cell myoblast program ?
"Although our adult stem cell myoblast program has been approved for a Phase II clinical trial, we have suspended that program indefinitely due to a lack of funding. As a result of our emphasis on our retinal program, our hemangioblast program and our blastomere program, our ability to progress as a company is more significantly hinged on the success of fewer programs and thus, a setback or adverse development relating to any one of them could potentially have a significant impact on share price as well as an inhibitory effect on our ability to raise additional capital................ If we are unable to develop our technologies, investors will likely lose their entire investment in us."
As filed with the Securities and Exchange Commission on October 20, 2011
Reg. No. 333-175019. POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
Great. Now I'm down only 58% and I have 10 "paths" after 3 years. Hopefully these lead to a more lucrative outcome than the first path. PS. Yesterday I sold 2/3 of my position when I was down 60%.
Bought DRYS with the proceeds in case you're interested.